Clinical Trial Update: Assessment of Effectiveness of Belatacept Patient Alert Card in Patients Following Renal Transplantation in a Sample of EU Countries

View source ↗

Summary

A completed clinical trial evaluated how effective a Belatacept patient alert card is for patients after renal transplantation across several EU countries.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Transplantation

Drugs mentioned

• belatacept (belatacept)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Renal Transplant | Status: COMPLETED